These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1629370)

  • 21. Improvement of gaze control after balance and eye movement training in patients with progressive supranuclear palsy: a quasi-randomized controlled trial.
    Zampieri C; Di Fabio RP
    Arch Phys Med Rehabil; 2009 Feb; 90(2):263-70. PubMed ID: 19236979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Striated anal sphincter denervation in patients with progressive supranuclear palsy.
    Valldeoriola F; Valls-Solé J; Tolosa ES; Marti MJ
    Mov Disord; 1995 Sep; 10(5):550-5. PubMed ID: 8552104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A follow-up study on brainstem atrophy in progressive supranuclear palsy--when does brain MRI contribute to the differential diagnosis between progressive supranuclear palsy and Parkinson disease?].
    Yamamoto T; Oya Y; Ogawa M; Ogata K; Kawai M
    Rinsho Shinkeigaku; 2003 Jul; 43(7):392-7. PubMed ID: 14582364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supranuclear palsy of voluntary eyelid closure: electrophysiological correlate.
    Grandas F; Esteban A
    Mov Disord; 1996 May; 11(3):329-31. PubMed ID: 8723154
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of motor, cognitive, and behavioral features in progressive supranuclear palsy and Parkinson's disease.
    Cordato NJ; Halliday GM; Caine D; Morris JG
    Mov Disord; 2006 May; 21(5):632-8. PubMed ID: 16353177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy.
    Sixel-Döring F; Schweitzer M; Mollenhauer B; Trenkwalder C
    Sleep Med; 2009 Apr; 10(4):407-15. PubMed ID: 18945638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
    Nicoletti G; Tonon C; Lodi R; Condino F; Manners D; Malucelli E; Morelli M; Novellino F; Paglionico S; Lanza P; Messina D; Barone P; Morgante L; Zappia M; Barbiroli B; Quattrone A
    Mov Disord; 2008 Dec; 23(16):2370-6. PubMed ID: 18816803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Applause sign" helps to discriminate PSP from FTD and PD.
    Dubois B; Slachevsky A; Pillon B; Beato R; Villalponda JM; Litvan I
    Neurology; 2005 Jun; 64(12):2132-3. PubMed ID: 15985587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progressive supranuclear palsy. Clinical and pharmacologic update.
    Jankovic J
    Neurol Clin; 1984 Aug; 2(3):473-86. PubMed ID: 6398402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limb apraxia in corticobasal degeneration and progressive supranuclear palsy.
    Soliveri P; Piacentini S; Girotti F
    Neurology; 2005 Feb; 64(3):448-53. PubMed ID: 15699373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Contribution of oculomotor examination for the etiological diagnosis of parkinsonian syndromes].
    Pierrot-Deseilligny Ch; Rivaud-Péchoux S
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S75-81. PubMed ID: 12773891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy.
    Pagonabarraga J; Horta-Barba A; Busteed L; Bejr-Kasem H; Illán-Gala I; Aracil-Bolaños I; Marín-Lahoz J; Pascual-Sedano B; Pérez J; Campolongo A; Izquierdo C; Martinez-Horta S; Sampedro F; Kulisevsky J
    Parkinsonism Relat Disord; 2021 Apr; 85():63-68. PubMed ID: 33744691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation of Parkinson's disease and progressive supranuclear palsy with magnetic resonance imaging: the first Brazilian experience.
    Barsottini OG; Ferraz HB; Maia AC; Silva CJ; Rocha AJ
    Parkinsonism Relat Disord; 2007 Oct; 13(7):389-93. PubMed ID: 17275393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gaze control and foot kinematics during stair climbing: characteristics leading to fall risk in progressive supranuclear palsy.
    Di Fabio RP; Zampieri C; Tuite P
    Phys Ther; 2008 Feb; 88(2):240-50. PubMed ID: 18073265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [An assessment of dysphagia using videofluorography in Parkinson's disease and progressive supranuclear palsy].
    Ichihara N; Ichihara SI; Fujii S; Touge T; Nishioka M
    Rinsho Shinkeigaku; 2000 Nov; 40(11):1076-82. PubMed ID: 11332186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of the vesicourethral function between progressive supranuclear palsy and Parkinson's disease].
    Wakatsuki A; Tsujihata M; Miyake O; Ito H; Itatani H; Udaka F
    Hinyokika Kiyo; 1993 Jun; 39(6):523-8. PubMed ID: 8337978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive supranuclear palsy.
    Esper CD; Weiner WJ; Factor SA
    Rev Neurol Dis; 2007; 4(4):209-16. PubMed ID: 18195676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
    Holmberg B; Rosengren L; Karlsson JE; Johnels B
    Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Steele-Richardson-Olszewski-syndrome--a report on 2 cases].
    Koop G; Gräf M
    Klin Monbl Augenheilkd; 2007 Oct; 224(10):799-803. PubMed ID: 17952826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eye movements in parkinsonian syndromes.
    Vidailhet M; Rivaud S; Gouider-Khouja N; Pillon B; Bonnet AM; Gaymard B; Agid Y; Pierrot-Deseilligny C
    Ann Neurol; 1994 Apr; 35(4):420-6. PubMed ID: 8154868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.